In late December 2021, the Biden Administration announced that health plans must cover diagnostic over-the-counter COVID-19 tests without cost-sharing or medical management requirements during the public health emergency.
On January 10, additional guidance was issued regarding this coverage beginning January 15, 2022 through the end of the public health emergency. The ruling does not require a plan to provide a point-of-sale solution at the pharmacy. However, your pharmacy plan is exploring options for delivering a point-of-sale solution for pharmacy customers and will share further information as soon as it becomes available. In addition, your pharmacy plan can reimburse you for the cost of any COVID-19 test if you purchase outside of your pharmacy network.
What you need to know:
Plans must cover OTC COVID-19 tests without cost sharing or medical management and may do so through post-payment reimbursement to the customer.
Plans are required to provide this coverage for up to 8 kits per covered member per month.
Plans may require the member to sign an attestation that the test(s):
Was purchased for the covered individual only
Was not used for employment purposes
Was not used for resale
For more information, please review the COVID website for Magellan.
Please submit your form and required documentation to the address listed on the COVID claim form. Do not submit this documentation to ABS/USHL as it will be returned to you.
